Recently, the team headed by Han Chunyu discovered the first “China-created†cutting-edge gene editing technology NgAgo-gDNA, which is known as the fourth-generation gene editing technology, breaking the patent monopoly of foreign gene editing technology and reaching the international first-class. Level, some people in the industry said that it is possible to surpass the CRISPR-Cas9 technology, but in addition to the advanced technology, we may also need to pay attention to some aspects of the technology side.
Talking about the Han Chunyu Nobel Prize Project: Talking about the Importance of Patent
In recent days, Associate Professor Han Chunyu’s report on the major original achievements of Nature Biotech has captured the headlines of many media and praised everyone. Many researchers believe that the NgAgo-gDNA technology reported by Han Chunyu is more suitable for human genome editing and will likely surpass the CRISPR-Cas9 technology. For professional interest, the author searched Han Chunyu's patent and found some problems, which were proposed for researcher's reference.
Han Chunyu and John van der Oost both published papers in nature
Let's take a look at Han Chunyu's entire process from producing research ideas to "Nature Biotech".
Han Chunyu's research on NgAgo was inspired by the article "DNA-guided DNA interference by a paokaryotic Argonaute" published by John van der Oost of Wageningen University (Netherlands) in the journal Nature. The article introduces TtAgo. (Thermus thermophilus Argonaute) can cut DNA using DNA as a template.
Inspired by van der Oost, the Han Chunyu team started experimenting in the first half of 2014. Two months later, NgAgo was able to do genetic editing tools. After the initial results of the experiment, Han Chunyu submitted a contribution to the journal Science. During the review of Science, Han Chunyu's research team continued to improve the experimental results. In the fall of 2014, Zhejiang University Shen Xiao also began to participate in this work. After a half-year review by Science magazine, Han Chunyu’s submission was eventually rejected. It is estimated that this time is about October. After supplementing the experimental content, the experimental paper was changed to "Nature Biotechnology" on June 3, 2015. After 9 months, the article was accepted in February 2016, and was published online on May 2, 2016. From the beginning of the study, to the publication of the paper, about two years before and after.
Also, let me introduce John van der Oost.
John van der Oost is currently working at Wageningen University in the Netherlands. He began researching the CRISPR field in 2005. He is a research member of the early CRISPR, working with both Zhang Feng and Jennifer Doudna. The latest public patent shows John van der Oost also at Caribou Biosciences. Among the inventors' list, the company was founded by Jennifer Doudna.
John van der Oost's article "DNA-guided DNAinterference by a paokaryotic Argonaute", submitted on July 30, 2013, was published on February 16, 2014.
Both Han Chunyu and John van der Oost applied for a patent.
First look at John van der Oost's patents filed around TtAgo:
Look at the patents applied by Han Chunyu:
Also in the field of genetic editing, the same results are published in the world's top journals. However, the protection of technological achievements is surprising. Han Chunyu's results were better than van der Oost's results. However, it was not until the second submission that he applied for a patent. There were two patent inventors, and the first inventor was Zhejiang University, and he did not apply for foreign patents. In contrast, van der Oost applied for a patent before submitting the manuscript, and then applied for a PCT international application. I think there should be no one in the field of genetic editing about the ownership of CRISPR-Cas9. In this case, such important results still have no active patent layout. This reflects that the attitudes and concepts of Chinese researchers on scientific research results remain in the laboratory, without considering the market application and what benefits the results can bring to society and humanity.
Steroids Powder name of steroids is adrenocorticosteroids. The adrenal glands of normal people secrete a certain amount of steroids every day to maintain normal physiological functions in the body, such as regulating the metabolism of blood sugar, protein, fat and electrolytes. It is an essential hormone to maintain life.
Steroid is widely distributed in the biological community of a large category of cyclopentane hydrophenanthrene derivatives, also known as steroids, steroids. Steroid compounds do not contain bound fatty acids and are non-saponifiable lipids; These compounds belong to isoprene like substances, which are formed by cyclization of triterpenes through intramolecular reorganization and chemical modification.
raw steroids powder,buy raw steroids powder,raw steroids powder for sale,steroids powder for sale,steroid powder buy
Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropic.com